(Q42810811)

7 November 2017

title

Activating mutations in the Met receptor overcome the requirement for autophosphorylation of tyrosines crucial for wild type signaling (English)

1 reference

7 November 2017

Jeffers MF

1

1 reference

7 November 2017

Vande Woude GF

series ordinal

2

1 reference

7 November 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

7 November 2017

1 reference

7 November 2017

volume

18

1 reference

7 November 2017

issue

36

1 reference

7 November 2017

page(s)

5120-5125

1 reference

Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud

7 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Molecular cloning of a new transforming gene from a chemically transformed human cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Mutations of the platelet-derived growth factor receptor that cause a loss of ligand-induced conformational change, subtle changes in kinase activity, and impaired ability to stimulate DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Interaction with the phosphotyrosine binding domain/phosphotyrosine interacting domain of SHC is required for the transforming activity of the FLT4/VEGFR3 receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Efficient cellular transformation by the Met oncoprotein requires a functional Grb2 binding site and correlates with phosphorylation of the Grb2-associated proteins, Cbl and Gab1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Eukaryotic protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

The mutationally activated Met receptor mediates motility and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Signaling requirements for oncogenic forms of the Met tyrosine kinase receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Activating mutations for the met tyrosine kinase receptor in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

The trk proto-oncogene encodes a receptor for nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Mechanism of met oncogene activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Signaling through scaffold, anchoring, and adaptor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Specific uncoupling of GRB2 from the Met receptor. Differential effects on transformation and motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Scatter factor/hepatocyte growth factor is essential for liver development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Catalytic specificity of protein-tyrosine kinases is critical for selective signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Scatter factor is a fibroblast-derived modulator of epithelial cell mobility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Mutation of juxtamembrane tyrosine residue 1001 suppresses loss-of-function mutations of the met receptor in epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Switching signals on or off by receptor dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202902

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1202902

1 reference

Dimensions Publication ID

7 November 2017

1031316471

0 references

1 reference